Market Overview:
The global medical sevofluran market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing use of sevofluran in pediatric patients and adults for general anesthesia. Additionally, the availability of generic drugs is also contributing to the growth of this market. However, factors such as side effects associated with sevofluran and stringent regulatory approvals are restraining the growth of this market.
Product Definition:
Sevofluran, also known as sevoflurane, is a general anesthetic used in surgery. It is a colorless gas with a slightly sweet odor. Sevofluran is usually given to patients through a face mask. It causes loss of consciousness and relaxation of muscles.
Generic Drug:
A generic drug is a pharmaceutical product that has an active ingredient similar to that of a branded medicine but which has been approved by the Food and Drug Administration (FDA) for sale in the U.S. as well as other countries. The FDA does not conduct clinical trials for generic drugs, instead it relies on data provided by the manufacturer of the original patented drug.
Original Drug:
Sevofluran is a semi-synthetic organic compound, which is also known as 9-fluorocarboxylic acid. It has a fluoro group and carboxylate anion (CAA). The molecule has C9F1 configuration in its chemical structure. It is usually found in nature as well as produced by some bacteria and plants.
Application Insights:
Based on the application, the global medical sevofluran market is segmented into children, adults and other applications. The other applications include cardiovascular diseases and respiratory diseases. In 2017, the children segment dominated with a share of over 60% in terms of revenue. This high share is attributable to increasing incidences of pediatric disorders that require treatment with generic drugs such as asthma and epilepsy which are manufactured using sevoflurane as a raw material.
The growing prevalence of neurological disorders coupled with rising awareness about alternative treatment options for these disorders has boosted demand for anesthetic agents that are used during surgical procedures such as C-sections which eventually led to higher market penetration in this segment over the past few years. However, growing awareness about side effects associated with general anesthetics may hinder market growth in this segment thereby affecting overall industry growth by 2030 negatively.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing R&D activities, presence of key manufacturers and suppliers, and rising adoption of modern healthcare practices in U.S., Canada, and Mexico.
Asia Pacific is expected to witness lucrative growth over the coming years owing to factors such as growing economy & population along with an increase in disposable income that will lead towards a rise in consumer awareness regarding health issues & treatments options available for them thus driving demand from end-use industries like pharmaceuticals.
Growth Factors:
- Increasing demand for general anesthesia and sedation in surgeries
- Rising geriatric population susceptible to various diseases
- Growing number of hospitals and clinics across the globe
- Technological advancements in medical devices and equipment
- Proliferation of private healthcare sector
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical Sevofluran Market Research Report
By Type
Generic Drug, Original Drug
By Application
Children, Adults
By Companies
Abbott Laboratories, Maruishi Pharmaceutical, Collins Ltd, Shenzhen Mindray Bio-Medical Electronics, Mylan Seiyaku, Baxter, Jinan MingRui, Scott Medical Products, BOC Healthcare, Abbvie, Piramal, Hengrui, Lunan, Hikma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
224
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Medical Sevofluran Market Report Segments:
The global Medical Sevofluran market is segmented on the basis of:
Types
Generic Drug, Original Drug
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Children, Adults
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Maruishi Pharmaceutical
- Collins Ltd
- Shenzhen Mindray Bio-Medical Electronics
- Mylan Seiyaku
- Baxter
- Jinan MingRui
- Scott Medical Products
- BOC Healthcare
- Abbvie
- Piramal
- Hengrui
- Lunan
- Hikma
Highlights of The Medical Sevofluran Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Generic Drug
- Original Drug
- By Application:
- Children
- Adults
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical Sevofluran Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Medical sevofluran is a medication used to treat asthma. It works by reducing the amount of air that your lungs can breathe.
Some of the major companies in the medical sevofluran market are Abbott Laboratories, Maruishi Pharmaceutical, Collins Ltd, Shenzhen Mindray Bio-Medical Electronics, Mylan Seiyaku, Baxter, Jinan MingRui, Scott Medical Products, BOC Healthcare, Abbvie, Piramal, Hengrui, Lunan, Hikma.
The medical sevofluran market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Medical Sevofluran Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Medical Sevofluran Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Medical Sevofluran Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Medical Sevofluran Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Medical Sevofluran Market Size & Forecast, 2020-2028
4.5.1 Medical Sevofluran Market Size and Y-o-Y Growth
4.5.2 Medical Sevofluran Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Generic Drug
5.2.2 Original Drug
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Children
6.2.2 Adults
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Medical Sevofluran Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Medical Sevofluran Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Generic Drug
9.6.2 Original Drug
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Children
9.10.2 Adults
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Generic Drug
10.6.2 Original Drug
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Children
10.10.2 Adults
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Generic Drug
11.6.2 Original Drug
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Children
11.10.2 Adults
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Generic Drug
12.6.2 Original Drug
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Children
12.10.2 Adults
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Generic Drug
13.6.2 Original Drug
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Children
13.10.2 Adults
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Medical Sevofluran Market: Competitive Dashboard
14.2 Global Medical Sevofluran Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Maruishi Pharmaceutical
14.3.3 Collins Ltd
14.3.4 Shenzhen Mindray Bio-Medical Electronics
14.3.5 Mylan Seiyaku
14.3.6 Baxter
14.3.7 Jinan MingRui
14.3.8 Scott Medical Products
14.3.9 BOC Healthcare
14.3.10 Abbvie
14.3.11 Piramal
14.3.12 Hengrui
14.3.13 Lunan
14.3.14 Hikma
